http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009005529-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_741abf159ab80be9ba7b8f7eb82c868f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5cb230f0a7cd7d6b56d135dfc0265392 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69bddb4c84704857f70d926c31a6e1a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c00ec5df12e8a68a41d021363c17f01e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0003 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-1219 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12099 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12136 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-12 |
| filingDate | 2007-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b9fab280af8a99947c31ac6b3115a9c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e94257b3806b45ffd63664132ea7f34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6defbb9489b6b556114e19ecc32ad7d5 |
| publicationDate | 2009-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2009005529-A1 |
| titleOfInvention | Osmotic devices and methods for diuretic therapy |
| abstract | Embodiments of the invention are related to devices and methods for modulating renal function, amongst other things. In an embodiment, the invention includes an implantable occlusive device including a wall member defining an enclosed volume, the wall member can include a semi-permeable membrane. The device can also include a solution comprising a solvent and a solute disposed within the enclosed volume of the wall member. The semi-permeable membrane can be permeable to the solvent and impermeable to the solute. The enclosed volume can be configured to expand and contract in response to changes in the osmolality of a bodily fluid. The device can include a positioning member configured to maintain the position of the implantable occlusive device relative to a lengthwise axis of a lymphatic vessel. In an embodiment, the invention includes a method of modulating renal function in a patient including implanting an occlusive device in the patient, the occlusive device comprising a semi-permeable membrane and configured to expand or contract based on the passage of a fluid across the semi-permeable membrane. Other aspects and embodiments are provided herein. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8475400-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8105261-B2 |
| priorityDate | 2007-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.